Back to companies

Mitsubishi Tanabe Pharma Corp: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders, and others. It also develops vaccines for preventing various infectious diseases. Mitsubishi Tanabe also offers major products for skin conditions and digestive medicines. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe, and North America. Mitsubishi Tanabe is headquartered in Osaka, Japan.

Headquarters Japan

Address 3-2-10, Dosho-machi, Chuo-ku, Osaka, 541-8505


Telephone 81 6 62055085

No of Employees 6,728

Industry Pharmaceuticals and Healthcare

Revenue (2021) $3.6B

   

   

Explore premium data & analytics

360+

Clinical Trials

Determine Mitsubishi Tanabe Pharma Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

160+

Catalyst Calendar

Proactively evaluate Mitsubishi Tanabe Pharma Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

140+

Marketed Drugs

Understand Mitsubishi Tanabe Pharma Corp’s commercialized product portfolio to stay one step ahead of the market.

130+

Pipeline Drugs

Identify which of Mitsubishi Tanabe Pharma Corp’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

100+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Mitsubishi Tanabe Pharma Corp’s relevant decision makers and contact details.

40+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

14+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

14+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

5

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

2

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products
Autoimmune Diseases:
Remicade (infliximab) - Rheumatoid Arthritis, Crohn’s Disease, Bechet’s Disease and others
Simponi (golimumab) - Rheumatoid Arthritis
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In February, the company successfully completed a three-year drug discovery research collaboration with HitGen Inc.
2022 Others In February, the company's sales rose 3.3% year on year.
2021 New Products/Services In June, the company launched Uplizna for I.V infusion 100mg for the treatment of relapses of neuromyelitis optica spectrum disorder.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Mitsubishi Tanabe Pharma Corp Astellas Pharma Inc Daiichi Sankyo Co Ltd Chugai Pharmaceutical Co Ltd Taisho Pharmaceutical Holdings Co Ltd
Headquarters Japan Japan Japan Japan Japan
City Osaka Chuo-Ku Chuo-Ku Chuo-Ku Toshima-Ku
State/Province Osaka Tokyo Tokyo Tokyo Tokyo
No. of Employees 6,728 15,455 16,033 7,664 9,195
Entity Type Private Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Hiroaki Ueno Representative Director; President; Chief Executive Officer Executive Board 2020 -
Eizo Tabaru Managing Executive Officer; Representative Director Executive Board - -
Yoshihiro Kobayashi Director; Managing Executive Officer Executive Board - -
Megumi Ohtaki Executive Officer Senior Management - -
Doi Toshihide Executive Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer